ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
97 347,29
-0,42%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Alector Inc (ALEC) Cours

Alector Inc

Alector Inc (ALEC)

NASDAQ
1,86
0,09
(5,08%)
Fermé 21 Décembre 10:00PM
Retardé de 15 minutes
1,8999
0,0399
(2,15%)
Après les heures de négociation: 1:58AM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
1,8999
Prix Achat
1,77
Prix Vente
1,94
Volume échangé
4 460 916
1,725 Fourchette du Jour 1,885
1,735 Plage de 52 semaines 8,90
Cap du marché
186,062M
Clôture Veille
1,77
Ouverture
1,78
Dernière Transaction
500
@
1.8999
(formt)
Dernière heure de transaction
Volume financier
US$ 8 028 165
VWAP
1,7997
Volume moyen (3 m)
1 112 581
Actions en circulation
97 932 605
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,40
Bénéfice par action (BPA)
-1,33
Chiffre d'affairess
97,06M
Bénéfice net
-130,39M

À propos de Alector Inc

Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to... Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline product inlcude AL001, AL002, AL003, and AL101. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.alector.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Alector Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker ALEC. Le dernier cours de clôture d'Alector était de US$1,77. Au cours de la dernière année, les actions de Alector ont été négociées dans une fourchette de prix de US$ 1,735 à US$ 8,90.

Alector compte actuellement 97 932 605 actions en circulation. La capitalisation boursière d'Alector est de US$173,34 million. Alector a un ratio cours/bénéfice (ratio PE) de -1.40.

ALEC Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

03 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 Décembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

29 Novembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

29 Novembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

29 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

25 Novembre 2024
Edgar (US Regulatory)

Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update

SOUTH SAN FRANCISCO, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering novel, genetically validated therapies for the...

25 Novembre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.1601-7.771844660192.062.061.73512852871.87065593CS
4-1.9101-50.13385826773.814.181.73521196302.46839078CS
12-2.9601-60.90740740744.866.141.73511125813.32589646CS
26-2.3701-55.50585480094.276.781.7358210874.07290469CS
52-6.4601-77.2739234458.368.91.7357347934.91213394CS
156-20.4401-91.495523724322.3424.0051.7356529877.72060724CS
260-17.6801-90.296731358519.58451.73570436414.40057768CS

ALEC - Frequently Asked Questions (FAQ)

What is the current Alector share price?
The current share price of Alector is US$ 1,8999
How many Alector shares are in issue?
Alector has 97 932 605 shares in issue
What is the market cap of Alector?
The market capitalisation of Alector is USD 173,34M
What is the 1 year trading range for Alector share price?
Alector has traded in the range of US$ 1,735 to US$ 8,90 during the past year
What is the PE ratio of Alector?
The price to earnings ratio of Alector is -1,4
What is the cash to sales ratio of Alector?
The cash to sales ratio of Alector is 1,88
What is the reporting currency for Alector?
Alector reports financial results in USD
What is the latest annual turnover for Alector?
The latest annual turnover of Alector is USD 97,06M
What is the latest annual profit for Alector?
The latest annual profit of Alector is USD -130,39M
What is the registered address of Alector?
The registered address for Alector is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Alector website address?
The website address for Alector is www.alector.com
Which industry sector does Alector operate in?
Alector operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ALEC
Alector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés